500 related articles for article (PubMed ID: 30104212)
21. [Immune effects research of interleukin 12 and Mycobacterium tuberculosis ESAT-6 antigen combined DNA immunization].
Hao M; Bao L; Gao L
Wei Sheng Wu Xue Bao; 2007 Jun; 47(3):477-81. PubMed ID: 17672309
[TBL] [Abstract][Full Text] [Related]
22. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
[TBL] [Abstract][Full Text] [Related]
23. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
Villarreal DO; Siefert RJ; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
[TBL] [Abstract][Full Text] [Related]
24. Immunological characteristics of Mycobacterium tuberculosis subunit vaccines immunized through different routes.
Lu Y; Kang J; Ning H; Wang L; Xu Y; Xue Y; Xu Z; Wu X; Bai Y
Microb Pathog; 2018 Dec; 125():84-92. PubMed ID: 30195646
[TBL] [Abstract][Full Text] [Related]
25. Chimaeric protein improved immunogenicity compared with fusion protein of Ag85B and ESAT-6 antigens of Mycobacterium tuberculosis.
Xu Y; Wang B; Chen J; Wang Q; Zhu B; Shen H; Qie Y; Wang J; Wang H
Scand J Immunol; 2006 Nov; 64(5):476-81. PubMed ID: 17032239
[TBL] [Abstract][Full Text] [Related]
26. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.
Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of Th1-Type Immune Responses to
Ko A; Wui SR; Ryu JI; Lee YJ; Hien DTT; Rhee I; Shin SJ; Park SA; Kim KS; Cho YJ; Lee NG
J Microbiol Biotechnol; 2018 Jan; 28(1):136-144. PubMed ID: 29081214
[TBL] [Abstract][Full Text] [Related]
28. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
Luo Y; Jiang W; Da Z; Wang B; Hu L; Zhang Y; An R; Yu H; Sun H; Tang K; Tang Z; Wang Y; Jing T; Zhu B
Scand J Immunol; 2012 Mar; 75(3):293-300. PubMed ID: 22117839
[TBL] [Abstract][Full Text] [Related]
29. The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.
Chen L; Xu M; Wang ZY; Chen BW; Du WX; Su C; Shen XB; Zhao AH; Dong N; Wang YJ; Wang GZ
FEMS Immunol Med Microbiol; 2010 Jun; 59(1):42-52. PubMed ID: 20298499
[TBL] [Abstract][Full Text] [Related]
30. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.
Li W; Deng G; Li M; Zeng J; Zhao L; Liu X; Wang Y
Mol Immunol; 2014 Nov; 62(1):86-95. PubMed ID: 24980867
[TBL] [Abstract][Full Text] [Related]
31. In vivo electroporation of a codon-optimized BER
Tang J; Cai Y; Liang J; Tan Z; Tang X; Zhang C; Cheng L; Zhou J; Wang H; Yam WC; Chen X; Wang H; Chen Z
Tuberculosis (Edinb); 2018 Dec; 113():65-75. PubMed ID: 30514515
[TBL] [Abstract][Full Text] [Related]
32. Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis.
Cai H; Tian X; Hu XD; Zhuang YH; Zhu YX
DNA Cell Biol; 2004 Jul; 23(7):450-6. PubMed ID: 15294094
[TBL] [Abstract][Full Text] [Related]
33. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
34. Recombinant Mycobacterium bovis BCG expressing the chimeric protein of antigen 85B and ESAT-6 enhances the Th1 cell-mediated response.
Xu Y; Liu W; Shen H; Yan J; Qu D; Wang H
Clin Vaccine Immunol; 2009 Aug; 16(8):1121-6. PubMed ID: 19515867
[TBL] [Abstract][Full Text] [Related]
35. [Prokaryotic expression and immunological characteristics of Mycobacterium tuberculosis Rv1886c].
Tao C; Zhao D; Dong H; Shan F; Lian K; Pan Z; Chen X; Yin Y; Jiao X
Wei Sheng Wu Xue Bao; 2014 Mar; 54(3):330-7. PubMed ID: 24984525
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
[TBL] [Abstract][Full Text] [Related]
37. Enhanced anti-tuberculosis immunity by a TAT-Ag85B protein vaccine in a murine tuberculosis model.
Dong H; Jing W; Yingru X; Wenyang W; Ru C; Shengfa N; Congjing X; Jingjing D; Wan W; Jiang H; Rongbo Z
Pathog Glob Health; 2015; 109(8):363-8. PubMed ID: 26924346
[TBL] [Abstract][Full Text] [Related]
38. T-bet acts as a powerful adjuvant in Ag85B DNA‑based vaccination against tuberculosis.
Hu D; Wu J; Zhang R; Chen L
Mol Med Rep; 2012 Jul; 6(1):139-44. PubMed ID: 22552442
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
Deng Y; Bao L; Yang X
Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
[TBL] [Abstract][Full Text] [Related]
40. H1:IC31 vaccination is safe and induces long-lived TNF-α
Mearns H; Geldenhuys HD; Kagina BM; Musvosvi M; Little F; Ratangee F; Mahomed H; Hanekom WA; Hoff ST; Ruhwald M; Kromann I; Bang P; Hatherill M; Andersen P; Scriba TJ;
Vaccine; 2017 Jan; 35(1):132-141. PubMed ID: 27866772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
